In March 2020, Zeposia secured its first regulatory approval for relapsing forms of Multiple Sclerosis. After the multiple myeloma CAR-T therapy approval, eyes will now be on the FDAs decision regarding Opdivos use for additional indications, as well as Zeposia in ulcerative colitis. The FDA is expected to review Bristol Myers Squibbs Opdivo for additional indications and Zeposia for treating ulcerative colitis. These T-Cells target and destroy any abnormal cells, including cancer cells. That said, the recent approval marks the only approved CAR-T therapy for the treatment of multiple myeloma.
Squibbs contains a PED that is an abbreviation for "Single Siber Blender".
( z0 contain :ARG0 ( z1 product :name ( z2 name :op "Squibbs" ) ) :ARG1 ( z3 protein :name ( z4 name :op "PED" ) :ARG1-of ( z5 nickname :ARG2 ( z6 thing :ARG1-of ( z7 single ) :ARG2-of ( z8 label ) ) ) ) )
(z0 / contain-01
    :ARG0 (z1 / product
              :name (z2 / name
                        :op1 "Squibbs"))
    :ARG1 (z3 / protein
              :name (z4 / name
                        :op1 "PED")
              :ARG1-of (z5 / nickname-01
                           :ARG2 (z6 / thing
                                     :ARG1-of (z7 / single-02)
                                     :ARG2-of (z8 / label-01)))))
Squibbs contains a PED that is an abbreviation for " Single Siber Blender " .
z1 :name z2
z2 :op1 1
z0 :ARG0 z1
z0 :ARG1 z3
z3 :name z4
z4 :op1 0
z3 :ARG1-of z5
z6 :ARG1-of z7
z5 :ARG2 z6
z6 :ARG2-of z8